As biosimilars reach the shelves, patients need pharmacists’ guidance

Patients will likely be introduced to biosimilars as cheaper versions of the biologic drugs—and they may assume the new products are “generics.” But while biosimilars are as clinically effective as the brand-name product and cost less, biosimilars are not exact replicas. As patients get accustomed to biosimilars, they will rely on their pharmacists’ knowledge.

http://www.pharmacytoday.org/article/S1042-0991(16)31217-8/fulltext